REFERENCES
- Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994;97:256–264.
- Rolston KV, Elting LS, Bodey GP. Bacteremia due to viridans streptococci in neutropenic patients. Am J Med. 1995;99:450.
- Barker GJ, Call SK, Gamis AS. Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis. J Pediatr Hematol Oncol. 1995;17:151–155.
- Ahmed R, Hassall T, Morland B, Gray J. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr Hematol Oncol. 2003;20:439–444.
- Marron A, Carratala J, Gonzalez-Barca E, Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126–1130.
- Paganini H, Staffolani V, Zubizarreta P, Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer. 2003;39:1284–1289.
- Richard P, Amador Del Valle G, Moreau P, Viridans streptococcal bacteraemia in patients with neutropenia. Lancet. 1995;345:1607–1609.
- Khan SA, Wingard JR. Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr. 2001;29:31–36.
- Okamoto Y, Ribeiro RC, Srivastava DK, Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. J Pediatr Hematol Oncol. 2003;25:696–703.
- Rossetti F, Cesaro S, Putti MC, Zanesco L. High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemia. Pediatr Hematol Oncol. 1995;12:387–392.
- Sotiropoulos SV, Jackson MA, Woods GM, Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J. 1989;8:755–758.
- Gassas A, Grant R, Richardson S, Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 2004;22:1222–1227.
- Huang WT, Chang LY, Hsueh PR, et al. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J Microbiol Immunol Infect. 2007;40:349–354.
- Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524–1529.
- Soto A, McWhinney PH, Kibbler CC, Cohen J. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine. 1998;10:370–376.
- Tasaka T, Nagai M, Sasaki K, et al. Streptococcus mitis septicemia in leukemia patients; clinical features and outcome. Intern Med. 1993;32:221–224.
- Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–1858.
- Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39:647–657.
- Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: the brain in sepsis—culprit and victim. Crit Care. 2005;9:37–44.
- Pytel P, Alexander JJ. Pathogenesis of septic encephalopathy. Curr Opin Neurol. 2009;22:283–287.
- Piazza O, Cotena S, De Robertis E, Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement. Neurochem Res. 2009;34:1289–1292.
- Siami S, Annane D, Sharshar T. The encephalopathy in sepsis. Crit Care Clin. 2008;24:67, 82, viii.
- Engel A, Kern P, Kern WV. Levels of cytokines and cytokine inhibitors in the neutropenic patient with alpha-hemolytic streptococcus shock syndrome. Clin Infect Dis. 1996;23:785–789.
- Ihendyane N, Sparrelid E, Wretlind B, et al. Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplant. 2004;33:79–85.